Experimental Infant Formula 1
Othermethod A phytate reduction and 5% protein hydrolysis
NCT Number: NCT02456831
This study evaluates the GI tolerance and acceptability of soy formulas fed to healthy term infants with reported intolerance to a milk-based formula.
Looking for future studies?
Notify Me2 week–9 week
All sexes
Interventional
Not applicable
Arkansas Children's Hospital, Little Rock, Arkansas, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
method A phytate reduction and 5% protein hydrolysis
method A phytate reduction and 10% protein hydrolysis
method B phytate reduction and 5% protein hydrolysis
Ready-to-Feed (RTF) Soy Infant Formula
Time frame: Change from Baseline (Study Day 1) to Study Day 15
stool number, consistency, and color
Time frame: Change from Baseline (Study Day 1) to Study Day 15
volume consumed
Time frame: Change from Baseline (Study Day 1) to Study Day 15
Incidence of spit up and vomiting
Time frame: Change from Baseline (Study Day 1) to Study Day 15
weight and weight gain
Abbott Nutrition
Industry
Efficacy of Soy Formula Feedings in Healthy, Term Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07426406
Gastrointestinal Tolerance
Newquay, Cornwall, United Kingdom
View Trial DetailsNCT06479330
Gastrointestinal Tolerance, Healthy Population
Toronto, Ontario, Canada
View Trial DetailsNCT07372482
Gastrointestinal Tolerance, Healthy Population
Toronto, Ontario, Canada
View Trial DetailsNCT05369494
Gastrointestinal Tolerance
Washington D.C., District of Columbia, United States
View Trial Details